fda compounding semaglutide enforcement november 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Moves to Permanently Close

When exposed to air, oxidized limonene may sensitize the skin

Trends Endocrin

Natural GLP-1 Support: Fiber, SCFAs, Akkermansia & Prebiotics What youll learn: Evidence-based strategies to support natural GLP-1 physiology through fiber, resistant starch, polyphenols, and beneficial microbes like Akkermansia

WilliamsBVan BenschotenACimermancicPDoniaMZimmermannMTaketaniMet alDiscovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine

Rossignol and Frye, 2012)

Farxiga (dapagliflozin) is one of the most well-known pharmaceuticals in the SGLT2 inhibitor class, which is one of the more recent pharmacological classes for treating Type 2 diabetes